Baczkó I - Search Results

1

KATP channel modulators increase survival rate during coronary occlusion-reperfusion in anaesthetized rats.

Baczkó I, Leprán I, Papp JG. Baczkó I, et al. Eur J Pharmacol. 1997 Apr 11;324(1):77-83. doi: 10.1016/s0014-2999(97)00064-2. Eur J Pharmacol. 1997. PMID: 9137916

2

ATP-sensitive potassium channel modulators: both pinacidil and glibenclamide produce antiarrhythmic activity during acute myocardial infarction in conscious rats.

Leprán I, Baczkó I, Varró A, Papp JG. Leprán I, et al. Among authors: baczko i. J Pharmacol Exp Ther. 1996 Jun;277(3):1215-20. J Pharmacol Exp Ther. 1996. PMID: 8667181

3

Influence of anesthetics on the incidence of reperfusion-induced arrhythmias and sudden death in rats.

Baczkó I, Leprán I, Papp JG. Baczkó I, et al. J Cardiovasc Pharmacol. 1997 Feb;29(2):196-201. doi: 10.1097/00005344-199702000-00007. J Cardiovasc Pharmacol. 1997. PMID: 9057068

4

Comparison of the efficacy of glibenclamide and glimepiride in reperfusion-induced arrhythmias in rats.

El-Reyani NE, Bozdogan O, Baczkó I, Leprán I, Papp JG. El-Reyani NE, et al. Among authors: baczko i. Eur J Pharmacol. 1999 Jan 22;365(2-3):187-92. doi: 10.1016/s0014-2999(98)00866-8. Eur J Pharmacol. 1999. PMID: 9988102

5

Antiarrhythmic and electrophysiological effects of GYKI-16638, a novel N-(phenoxyalkyl)-N-phenylalkylamine, in rabbits.

Baczkó I, El-Reyani NE, Farkas A, Virág L, Iost N, Leprán I, Mátyus P, Varró A, Papp JG. Baczkó I, et al. Eur J Pharmacol. 2000 Sep 15;404(1-2):181-90. doi: 10.1016/s0014-2999(00)00591-4. Eur J Pharmacol. 2000. PMID: 10980278

6

Effect of glibenclamide and glimepiride treatment on the development of myocardial infarction in rats.

El-Reyani NE, Baczkó I, Leprán I, Papp JG. El-Reyani NE, et al. Among authors: baczko i. Acta Physiol Hung. 2000;87(2):173-84. Acta Physiol Hung. 2000. PMID: 11205966

7

Combined pharmacological block of I(Kr) and I(Ks) increases short-term QT interval variability and provokes torsades de pointes.

Lengyel C, Varró A, Tábori K, Papp JG, Baczkó I. Lengyel C, et al. Among authors: baczko i. Br J Pharmacol. 2007 Aug;151(7):941-51. doi: 10.1038/sj.bjp.0707297. Epub 2007 May 29. Br J Pharmacol. 2007. PMID: 17533421 Free PMC article.

8

Selective cardiac plasma-membrane K(ATP) channel inhibition is defibrillatory and improves survival during acute myocardial ischemia and reperfusion.

Vajda S, Baczkó I, Leprán I. Vajda S, et al. Among authors: baczko i. Eur J Pharmacol. 2007 Dec 22;577(1-3):115-23. doi: 10.1016/j.ejphar.2007.08.016. Epub 2007 Aug 19. Eur J Pharmacol. 2007. PMID: 17904545

9

Increased short-term variability of the QT interval in professional soccer players: possible implications for arrhythmia prediction.

Lengyel C, Orosz A, Hegyi P, Komka Z, Udvardy A, Bosnyák E, Trájer E, Pavlik G, Tóth M, Wittmann T, Papp JG, Varró A, Baczkó I. Lengyel C, et al. Among authors: baczko i. PLoS One. 2011 Apr 15;6(4):e18751. doi: 10.1371/journal.pone.0018751. PLoS One. 2011. PMID: 21526208 Free PMC article.

10

Class I/B antiarrhythmic property of ranolazine, a novel antianginal agent, in dog and human cardiac preparations.

Szél T, Koncz I, Jost N, Baczkó I, Husti Z, Virág L, Bussek A, Wettwer E, Ravens U, Papp JG, Varró A. Szél T, et al. Among authors: baczko i. Eur J Pharmacol. 2011 Jul 15;662(1-3):31-9. doi: 10.1016/j.ejphar.2011.04.042. Epub 2011 May 1. Eur J Pharmacol. 2011. PMID: 21550338

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

105 results

Search Page

Filters